These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 23046857)
21. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation. Song H; Lim H Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727 [TBL] [Abstract][Full Text] [Related]
23. Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor. Thiel S; Behrmann I; Timmermann A; Dahmen H; Müller-Newen G; Schaper F; Tavernier J; Pitard V; Heinrich PC; Graeve L Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):15-9. PubMed ID: 10085222 [TBL] [Abstract][Full Text] [Related]
24. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
25. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Lehmann S; Paul C; Törmä H Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892 [TBL] [Abstract][Full Text] [Related]
26. The role of bone marrow transplantation in acute promyelocytic leukemia. Nabhan C; Mehta J; Tallman MS Bone Marrow Transplant; 2001 Aug; 28(3):219-26. PubMed ID: 11535988 [TBL] [Abstract][Full Text] [Related]
27. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Tallman MS Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584 [TBL] [Abstract][Full Text] [Related]
28. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia. Quezada G; Kopp L; Estey E; Wells RJ Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388 [TBL] [Abstract][Full Text] [Related]
29. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859 [TBL] [Abstract][Full Text] [Related]
30. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267 [TBL] [Abstract][Full Text] [Related]
31. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors. Nakamura T; Arai T; Takagi M; Sawada T; Matsuda T; Yokota T; Heike T Biochem Biophys Res Commun; 1998 Jul; 248(1):22-7. PubMed ID: 9675079 [TBL] [Abstract][Full Text] [Related]
32. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells. Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297 [TBL] [Abstract][Full Text] [Related]
33. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia. Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666 [TBL] [Abstract][Full Text] [Related]
34. How to manage acute promyelocytic leukemia. Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168 [TBL] [Abstract][Full Text] [Related]
35. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780 [TBL] [Abstract][Full Text] [Related]
38. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1. Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of two new mixed-ligand Cu(II) complexes of a tridentate NN'O type Schiff base ligand and N-donor heterocyclic co-ligands: In vitro anticancer assay, DNA/human leukemia/COVID-19 molecular docking studies, and pharmacophore modeling. Ghasemi L; Behzad M; Khaleghian A; Abbasi A; Abedi A Appl Organomet Chem; 2022 May; 36(5):e6639. PubMed ID: 35538931 [TBL] [Abstract][Full Text] [Related]
40. Leukemia inhibitory factor receptor α-chain: a potential method for acute promyeloid leukemia therapy. Sun Q; Gao G; Xiong J; Wu Q; Liu H Med Hypotheses; 2012 Dec; 79(6):864-6. PubMed ID: 23046857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]